Peptron Inc (087010) - Total Assets
Based on the latest financial reports, Peptron Inc (087010) holds total assets worth ₩167.98 Billion KRW (≈ $113.83 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Peptron Inc - Total Assets Trend (2014–2025)
This chart illustrates how Peptron Inc's total assets have evolved over time, based on quarterly financial data. Also see 087010 stock market capitalisation for the company's overall valuation and market capitalisation.
Peptron Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Peptron Inc's total assets of ₩167.98 Billion consist of 64.4% current assets and 35.6% non-current assets. Review Peptron Inc (087010) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 2.5% |
| Accounts Receivable | ₩611.58 Million | 0.3% |
| Inventory | ₩1.77 Billion | 1.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩3.18 Billion | 1.8% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Peptron Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 087010 stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Peptron Inc's current assets represent 64.4% of total assets in 2025, an increase from 47.7% in 2014.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, down from 4.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 1.8% of total assets.
Peptron Inc Competitors by Total Assets
Key competitors of Peptron Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pluristem
TA:PSTI
|
Israel | ILA79.13 Million |
|
Hadasit Bio
TA:HDST
|
Israel | ILA14.67 Million |
|
Purple Biotech Ltd
TA:KTOV
|
Israel | ILA85.78 Million |
|
Bioneer Corporation
KQ:064550
|
Korea | ₩376.52 Billion |
|
MEDIPOST Co. Ltd
KQ:078160
|
Korea | ₩374.57 Billion |
|
Cell Biotech Co. Ltd
KQ:049960
|
Korea | ₩134.57 Billion |
|
Macrogen Inc
KQ:038290
|
Korea | ₩341.60 Billion |
|
Panagene Inc
KQ:046210
|
Korea | ₩101.91 Billion |
Peptron Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.11 | 22.40 | 23.57 |
| Quick Ratio | 8.91 | 22.32 | 23.46 |
| Cash Ratio | 0.00 | 0.00 | 1.72 |
| Working Capital | ₩73.34 Billion | ₩102.19 Billion | ₩34.94 Billion |
Peptron Inc - Advanced Valuation Insights
This section examines the relationship between Peptron Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 26.21 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 6.0% |
| Total Assets | ₩178.98 Billion |
| Market Capitalization | $1.57 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Peptron Inc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Peptron Inc's assets grew by 6.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Peptron Inc (2014–2025)
The table below shows the annual total assets of Peptron Inc from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩178.98 Billion ≈ $121.29 Million |
+5.97% |
| 2024-12-31 | ₩168.89 Billion ≈ $114.46 Million |
+221.73% |
| 2023-12-31 | ₩52.50 Billion ≈ $35.58 Million |
-23.11% |
| 2022-12-31 | ₩68.27 Billion ≈ $46.27 Million |
-12.32% |
| 2021-12-31 | ₩77.87 Billion ≈ $52.77 Million |
-33.84% |
| 2020-12-31 | ₩117.70 Billion ≈ $79.76 Million |
+93.00% |
| 2019-12-31 | ₩60.99 Billion ≈ $41.33 Million |
-15.01% |
| 2018-12-31 | ₩71.76 Billion ≈ $48.63 Million |
+35.27% |
| 2017-12-31 | ₩53.05 Billion ≈ $35.95 Million |
-8.38% |
| 2016-12-31 | ₩57.90 Billion ≈ $39.24 Million |
+167.36% |
| 2015-12-31 | ₩21.66 Billion ≈ $14.68 Million |
+87.08% |
| 2014-12-31 | ₩11.58 Billion ≈ $7.84 Million |
-- |
About Peptron Inc
Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, … Read more